Transjugular intrahepatic portosystemic shunt
Transjugular intrahepatic portosystemic shunt | |
---|---|
hepatic vein and after needle puncture, a guidewire was passed into a portal vein branch. The tract was dilated with a balloon, and contrast injected. A self-expandable metallic stent has yet to be placed over the wire. | |
Other names | Transjugular intrahepatic portosystemic stent shunting |
Specialty | Interventional radiology |
ICD-9-CM | 39.1 |
MeSH | D019168 |
Transjugular intrahepatic portosystemic shunt (TIPS or TIPSS) is an artificial channel within the
An
The procedure was first described by
Medical uses
TIPS is a life-saving procedure in bleeding from esophageal or gastric varices. A randomized study showed that the survival is better if the procedure is done within 72 hours after bleeding.[2] TIPS has shown some promise for people with hepatorenal syndrome.[3] It may also help with ascites.[4]
Complications
Severe procedural complications during a TIPS procedure, including catastrophic bleeding or direct liver injury, are relatively uncommon. In the hands of an experienced physician, operative mortality is less than 1%[medical citation needed]. On the other hand, up to 25% of patients who undergo TIPS will experience transient post-operative hepatic encephalopathy caused by increased porto-systemic passage of nitrogen from the gut.[5]
A less common, but more serious complication, is hepatic ischemia causing acute liver failure. While healthy livers are predominantly oxygenated by portal blood supply, long-standing portal hypertension results in compensatory hypertrophy of and increased reliance on the hepatic artery for oxygenation. Thus, in people with advanced liver disease the shunting of portal blood away from hepatocytes is usually well tolerated. However, in some cases suddenly shunting portal blood flow away from the liver may result in acute liver failure secondary to hepatic ischemia.[6] Acute hepatic dysfunction after TIPS may require emergent closure of the shunt.[citation needed]
A rare but serious complication is persistent TIPS infection, also known as endotipsitis.[7]
Lastly, the TIPS may become blocked by a blood clot or in-growth of endothelial cells and no longer function. This has been significantly reduced with the use of polytetrafluoroethylene (PTFE)–covered stents.[8]
Mechanism of action
Portal hypertension, an important consequence of liver disease, results in the development of significant
A TIPS procedure decreases the effective vascular resistance of the liver through the creation of an alternative pathway for portal venous circulation. By creating a shunt from the portal vein to the hepatic vein, this intervention allows portal blood an alternative avenue for draining into systemic circulation. In bypassing the flow-resistant liver, the net result is a reduced pressure drop across the liver and a decreased portal venous pressure. Decreased portal venous pressure in turn lessens congestive pressures along veins in the intestine so that future bleeding is less likely to occur. The reduced pressure also makes less fluid develop, although this benefit may take weeks or months to occur.[citation needed]
Implantation
Transjugular intrahepatic portosystemic shunts are typically placed by an interventional radiologist under
Once the catheter is in the hepatic vein, a wedge pressure is obtained to calculate the pressure gradient in the liver. Following this, carbon dioxide is injected to locate the portal vein. Then, a special needle known as a Colapinto is advanced through the liver parenchyma to connect the hepatic vein to the large portal vein, near the center of the liver. The channel for the shunt is next created by inflating an angioplasty balloon within the liver along the tract created by the needle. The shunt is completed by placing a special mesh tube known as a stent or endograft to maintain the tract between the higher-pressure portal vein and the lower-pressure hepatic vein. After the procedure, fluoroscopic images are made to show placement. Pressure in the portal vein and inferior vena cava are often measured.[citation needed]
See also
- Balloon-occluded retrograde transvenous obliteration
- Distal splenorenal shunt procedure
- Gastric antral vascular ectasia
- Portal venous system
References
- S2CID 32164746.
- PMID 20573925.
- PMID 15381144.
- ^ "Ascites - Hepatic and Biliary Disorders". Merck Manuals Professional Edition. May 2016. Retrieved 14 December 2017.
- ^ Rossle M, Piotraschke J. Transjugular intrahepatic portosystemic shunt and hepatic encephalopathy. Dig Dis 1996; 14:12–19.
- ^ Mayan H, Kantor R, Rimon U, Golubev N, Heyman Z, Goshen E, Shalmon B, Weiss P.: "Fatal liver infarction after transjugular intrahepatic portosystemic shunt procedure." Liver, 2001;21(5):361-4.
- PMID 19929905.
- PMID 23811307.
- ^ "What You Need to Know about the Transjugular Intrahepatic Portosystemic Shunt (TIPS)". Cleveland Clinic.